½ÃÀ庸°í¼­
»óǰÄÚµå
1525279

¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð Á¶»ç : ÃÖÁ¾ »ç¿ëÀÚ, ±¸¼º ¿ä¼Ò, ¹èÆ÷ ¸ðµå, ±â´É ¹× Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Patient Engagement Solutions Market Size study, by End User, by Component, by Deployment Mode, by Functionality, and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ȯÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀåÀº 2023³â ¾à 189¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2032³â±îÁö 11.5% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ȯÀÚ Âü¿© ¼Ö·ç¼ÇÀº ȯÀÚ°¡ ÀÇ·á ¼­ºñ½º¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ȯÀÚ ¼º°ú¿Í °æÇèÀ» °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒÇÁÆ®¿þ¾î¿Í µðÁöÅÐ Ç÷§ÆûÀ» ÅëÇØ ȯÀÚ´Â ÀÚ½ÅÀÇ ÀÇ·á Á¤º¸¿¡ Á¢±ÙÇϰí, ¿¹¾àÇϰí, ÀÇ·áÁø°ú ¼ÒÅëÇÒ ¼ö ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇϰí, ÀÇ»ç °áÁ¤ °øÀ¯¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ´Â °Ç°­ »óŸ¦ °ü¸®Çϰí ÀÇ·á Àü¹®°¡¿Í ¼ÒÅëÇϱâ À§ÇØ µðÁöÅÐ ¼Ö·ç¼ÇÀ» »ç¿ëÇÒ ÀÇÇâÀÌ ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. °¡»ó µµ±¸ÀÇ Æí¸®ÇÔ°ú Á¢±Ù¼ºÀº ÀÇ·á Àü¹®°¡¿Í ȯÀÚ ¸ðµÎ¿¡°Ô ÇʼöÀûÀÎ »ý¸íÁÙÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¼¼°è ȯÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀåÀº ±¹¹ÎµéÀÇ ¸ð¹ÙÀÏ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ºÐ¾ß¿Í °³ÀÎµé »çÀÌ¿¡¼­ ½º¸¶Æ®Æù ´Ü¸»±âÀÇ º¸±ÞÀÌ È®»êµÇ¸é¼­ ¼¼°è ȯÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀå¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °í°´µéÀº °Ç°­ ¸ð´ÏÅ͸µ, ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀ» ÅëÇÑ ±¸¸Å, ¸ð¹ÙÀÏ¿¡ ÃÖÀûÈ­µÈ À¥»çÀÌÆ®¸¦ À§ÇØ ÈÞ´ëÀüÈ­¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ȯÀÚ Âü¿© ¼Ö·ç¼ÇÀº ƯÈ÷ ½º¸¶Æ®Æù ¹× ±âŸ µðÁöÅÐ ±â¼úÀ» ÅëÇØ ÇコÄÉ¾î »ç¾÷ÀÚÀÇ IT ¹× Á¦¾î ½Ã½ºÅÛ È°¿ëÀ» °­È­Çϱâ À§ÇØ È¯ÀÚ Âü¿© ¼Ö·ç¼ÇÀÌ Å« ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀüÀÚ ÀÇ·á ±â·Ï(EHR) º¸°í¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¼¼°è ȯÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀå¿¡ ÀÖ¾î °¡Àå Å« µµÀü °úÁ¦´Â ³ôÀº µµÀÔ ºñ¿ë°ú À¯Áöº¸¼ö ºñ¿ëÀÔ´Ï´Ù. ÇÁ·Î±×·¥ ±¸¸Å, ÀÎÇÁ¶ó ±¸Ãà, ±âÁ¸ ÀÇ·á ½Ã½ºÅÛ°úÀÇ ÅëÇÕ°ú °ü·ÃµÈ Ãʱ⠺ñ¿ëÀº »ó´çÇÑ ±Ý¾×ÀÌ ¼Ò¿äµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ Âü¿© ¼Ö·ç¼Ç¿¡´Â ¶óÀ̼±½º ºñ¿ë°ú ¸â¹ö½Ê ºñ¿ëÀÌ ºÎ°úµÇ´Â °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ·¯ÇÑ ºñ¿ëÀº Á¤±âÀûÀ¸·Î ÁöÃâµÇ´Â ºñ¿ëÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ôÀº Ãʱ⠺ñ¿ëÀÌ È¯ÀÚ Âü¿© ¼Ö·ç¼ÇÀÇ È®»êÀ» °¡·Î¸·´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, È¿À²ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç ¾ÈÀüÇÑ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ °íµµ·Î Á¤±³ÇÑ ±â¼ú°ú ±¸¼º¿ä¼Ò¸¦ ÅëÇÕÇÏ´Â µ¥´Â ³ôÀº ºñ¿ëÀÌ ¼Ò¿äµÇ¸ç, ÀÌ´Â ¶Ç ´Ù¸¥ µµÀü°úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù.

ȯÀÚ Âü¿© ¼Ö·ç¼Ç°ú ±âÁ¸ ÀÇ·á ÀÎÇÁ¶ó ±¸¼º ¿ä¼ÒÀÇ ÅëÇÕÀÇ º¹À⼺ÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¶Á÷Àº ´Ù¾çÇÑ ±â¼úÀ» »ç¿ëÇÏ´Â ´Ù¾çÇÑ ¾Û°ú ¼ÒÇÁÆ®¿þ¾î¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ÅëÇÕ ÇÁ·Î¼¼½º°¡ º¹ÀâÇÏ°í ±î´Ù·Ó½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅͰ¡ ¼­·Î ´Ù¸¥ Áö¸®Àû À§Ä¡¿¡ ÀúÀåµÇ°í 󸮵Ǵ °æ¿ì, µ¥ÀÌÅÍ °ÅÁÖÁö ¹× °üÇÒ±Ç ¿ä±¸ »çÇ×ÀÌ ¿ì·Á¸¦ À¯¹ßÇÏ°í ½ÃÀå ¼ºÀåÀ» ´õ¿í ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â Oracle(Oracle Corporation), IBM Corporation°ú °°Àº ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ 22023³â °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Áö¿ª Àüü¿¡¼­ ÀÇ·á ÀÎÇÁ¶ó¸¦ °­È­Çϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í À̸¦ Áö¿øÇϱâ À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê°¡ ÀÖ½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº µðÁöÅÐÈ­ È®»ê°ú ÷´Ü ±â¼ú äÅÃÀÌ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ¾î ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ÄÄÆ÷³ÍÆ®º°
    • Àü°³ ¸ðµåº°
    • ±â´Éº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±âÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦2Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼ú Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó ³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • ÀÇ·á Á¦°øÀÚ
    • ÀÇ·áºñ ÁöºÒÀÚ
    • ȯÀÚ

Á¦6Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÄÄÆ÷³ÍÆ®º°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå : ÄÄÆ÷³ÍÆ®º° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àü°³ ¸ðµåº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå : Àü°³ ¸ðµåº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • ¿ÂÇÁ·¹¹Ì½º
    • Ŭ¶ó¿ìµå

Á¦8Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±â´Éº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå : ±â´Éº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â/2032³â
    • Ä¿¹Â´ÏÄÉÀ̼Ç
    • °Ç°­ ÃßÀû ¹× ÀλçÀÌÆ®
    • û±¸ ¹× ÁöºÒ
    • °ü¸®
    • ±âŸ

Á¦9Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Aetna Inc.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • Athenahealth
    • McKesson Corporation.
    • Allscripts Healthcare Solutions, Inc.(Veradigm LLC)
    • GetWellNetwork, Inc.
    • Lumeon Inc.
    • IQVIA Inc.
    • Philips Healthcare
    • Cerner Corporation
    • GE Healthcare
    • Siemens Healthineers
    • Medtroni
    • Oracle Corporation
    • IBM Corporation
    • EPIC Systems Corporation

Á¦11Àå Á¶»ç °úÁ¤

LSH 24.08.20

Global Patient Engagement Solutions Market is valued approximately at USD 18.96 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 11.5% over the forecast period 2024-2032. Patient engagement solutions play a crucial role in empowering patients to actively participate in their healthcare journey, fostering better patient outcomes and experiences. These software and digital platforms enable patients to access their medical information, schedule appointments, and communicate with healthcare providers, thereby allowing remote patient monitoring and encouraging shared decision-making. A study by Accenture highlighted that 60% of patients are ready to use digital solutions to manage health conditions and communicate with healthcare professionals. The convenience and accessibility of virtual tools make them an essential lifeline for healthcare professionals and patients alike.

The global patient engagement solutions market has experienced significant growth, primarily driven by increased awareness regarding mobile health among the populace. The proliferation of smartphone devices across various sectors and among individuals has directly influenced the growth of the global patient engagement solutions market. Customers are increasingly using their mobile phones for health monitoring, purchasing through mobile applications, or mobile-optimized websites. Consequently, patient engagement solutions have gained significant traction to enhance the use of IT and control systems among healthcare operators, particularly through smartphone usage and other digital technologies. Furthermore, the growing emphasis on electronic health record (EHR) reports has fueled the adoption of patient monitoring solutions.

The major challenge for the growth of the global patient engagement solutions market lies in the high implementation and maintenance costs. Initial expenses related to purchasing the program, setting up infrastructure, and integrating it into existing healthcare systems can be significant. Additionally, patient engagement solutions often come with licensing or membership fees, which can be recurring expenses. These high upfront costs have restrained the adoption of patient engagement solutions globally. Moreover, the integration of highly sophisticated technologies and components to provide efficient, reliable, and safe services comes with high costs, posing another challenge.

Integration complexities of patient engagement solutions with existing healthcare infrastructure components are key constraints for the market's growth. Organizations frequently utilize a range of apps and software using various technologies, making the integration process complex and challenging. Additionally, data residency and jurisdictional requirements raise concerns when data is stored and processed in different geographic locations, further hindering market growth.

The key regions considered for the global patient engagement solutions market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America held the largest market share in 2023, driven by the presence of major players such as Oracle Corporation and IBM Corporation. Government initiatives aimed at strengthening healthcare infrastructure across the region and supportive government initiatives. In contrast, the Asia-Pacific region is expected to grow at the fastest rate over the forecast period. The increased penetration of digitalization and higher adoption of advanced technology in this region is expected to provide lucrative growth opportunities for the market.

Major market players included in this report are:

  • Oracle Corporation
  • IBM Corporation
  • EPIC Systems Corporation
  • Athenahealth
  • McKesson Corporation
  • GetWellNetwork, Inc.
  • Allscripts Healthcare Solutions, Inc. (Veradigm LLC)
  • Lumeon Inc.
  • IQVIA Inc.
  • Aetna Inc.
  • Philips Healthcare
  • Cerner Corporation
  • GE Healthcare
  • Medtronic
  • Siemens Healthineers

The detailed segments and sub-segment of the market are explained below:

By End User:

  • Providers
  • Payers
  • Patients

By Component:

  • Hardware
  • Software
  • Services

By Deployment Mode:

  • On-premise
  • Cloud

By Functionality:

  • Communication
  • Health Tracking and Insights
  • Billing and Payments
  • Administrative
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Patient Engagement Solutions Market Executive Summary

  • 1.1. Global Patient Engagement Solutions Market Size & Forecast (2022- 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By End User
    • 1.3.2. By Component
    • 1.3.3. By Deployment Mode
    • 1.3.4. By Functionality
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Patient Engagement Solutions Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Patient Engagement Solutions Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Advancements in Healthcare Technology
    • 3.1.2. Rise in Awareness Regarding Mobile Health
    • 3.1.3. Government Initiatives for Healthcare Digitalization
  • 3.2. Market Challenges
    • 3.2.1. High Implementation and Maintenance Costs
    • 3.2.2. Integration Complexities with Existing Healthcare Systems
    • 3.2.3. Data Residency and Jurisdictional Requirements
  • 3.3. Market Opportunities
    • 3.3.1. Increasing Penetration of Digitalization in Emerging Markets
    • 3.3.2. Development of Innovative Mobile Health Applications
    • 3.3.3. Expansion of Telehealth Services

Chapter 4. Global Patient Engagement Solutions Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Patient Engagement Solutions Market Size & Forecasts by End User 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Patient Engagement Solutions Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Providers
    • 5.2.2. Payers
    • 5.2.3. Patients

Chapter 6. Global Patient Engagement Solutions Market Size & Forecasts by Component 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Patient Engagement Solutions Market: Component Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Hardware
    • 6.2.2. Software
    • 6.2.3. Services

Chapter 7. Global Patient Engagement Solutions Market Size & Forecasts by Deployment Mode 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Patient Engagement Solutions Market: Deployment Mode Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. On-premise
    • 7.2.2. Cloud

Chapter 8. Global Patient Engagement Solutions Market Size & Forecasts by Functionality 2022-2032

  • 8.1. Segment Dashboard
  • 8.2. Global Patient Engagement Solutions Market: Functionality Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 8.2.1. Communication
    • 8.2.2. Health Tracking and Insights
    • 8.2.3. Billing and Payments
    • 8.2.4. Administrative
    • 8.2.5. Others

Chapter 9. Global Patient Engagement Solutions Market Size & Forecasts by Region 2022-2032

  • 9.1. North America Patient Engagement Solutions Market
    • 9.1.1. U.S. Patient Engagement Solutions Market
      • 9.1.1.1. End User breakdown size & forecasts, 2022-2032
      • 9.1.1.2. Component breakdown size & forecasts, 2022-2032
      • 9.1.1.3. Deployment Mode breakdown size & forecasts, 2022-2032
      • 9.1.1.4. Functionality breakdown size & forecasts, 2022-2032
    • 9.1.2. Canada Patient Engagement Solutions Market
  • 9.2. Europe Patient Engagement Solutions Market
    • 9.2.1. UK Patient Engagement Solutions Market
    • 9.2.2. Germany Patient Engagement Solutions Market
    • 9.2.3. France Patient Engagement Solutions Market
    • 9.2.4. Spain Patient Engagement Solutions Market
    • 9.2.5. Italy Patient Engagement Solutions Market
    • 9.2.6. Rest of Europe Patient Engagement Solutions Market
  • 9.3. Asia-Pacific Patient Engagement Solutions Market
    • 9.3.1. China Patient Engagement Solutions Market
    • 9.3.2. India Patient Engagement Solutions Market
    • 9.3.3. Japan Patient Engagement Solutions Market
    • 9.3.4. Australia Patient Engagement Solutions Market
    • 9.3.5. South Korea Patient Engagement Solutions Market
    • 9.3.6. Rest of Asia Pacific Patient Engagement Solutions Market
  • 9.4. Latin America Patient Engagement Solutions Market
    • 9.4.1. Brazil Patient Engagement Solutions Market
    • 9.4.2. Mexico Patient Engagement Solutions Market
    • 9.4.3. Rest of Latin America Patient Engagement Solutions Market
  • 9.5. Middle East & Africa Patient Engagement Solutions Market
    • 9.5.1. Saudi Arabia Patient Engagement Solutions Market
    • 9.5.2. South Africa Patient Engagement Solutions Market
    • 9.5.3. Rest of Middle East & Africa Patient Engagement Solutions Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Aetna Inc.
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Market Strategies
    • 10.3.2. Athenahealth
    • 10.3.3. McKesson Corporation.
    • 10.3.4. Allscripts Healthcare Solutions, Inc. (Veradigm LLC)
    • 10.3.5. GetWellNetwork, Inc.
    • 10.3.6. Lumeon Inc.
    • 10.3.7. IQVIA Inc.
    • 10.3.8. Philips Healthcare
    • 10.3.9. Cerner Corporation
    • 10.3.10. GE Healthcare
    • 10.3.11. Siemens Healthineers
    • 10.3.12. Medtroni
    • 10.3.13. Oracle Corporation
    • 10.3.14. IBM Corporation
    • 10.3.15. EPIC Systems Corporation

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦